Gemcitabine Exposure Induces Epigenomic Remodeling in Pancreatic Cancer Cells during Resistance Development

被引：0
|
作者：
Urrutia, Guillermo [1 ]
Dusetti, Nelson [2 ]
Iovanna, Juan [2 ]
Urrutia, Raul [1 ]
Lomberk, Gwen [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI USA
[2] Ctr Rech Cancerol Marseille, Marseille, France
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.05341
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer
    Li Wei
    Jing-Yun Wen
    Jie Chen
    Xiao-Kun Ma
    Dong-Hao Wu
    Zhan-Hong Chen
    Jiang-Long Huang
    World Journal of Gastroenterology, 2019, (37) : 5590 - 5603
  • [22] Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer
    Wei, Li
    Wen, Jing-Yun
    Chen, Jie
    Ma, Xiao-Kun
    Wu, Dong-Hao
    Chen, Zhan-Hong
    Huang, Jiang-Long
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (37) : 5590 - 5603
  • [23] Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells
    Maehara, S
    Tanaka, S
    Shimada, M
    Shirabe, K
    Saito, Y
    Takahashi, K
    Maehara, Y
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (02) : 184 - 189
  • [24] Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
    S Bafna
    S Kaur
    N Momi
    S K Batra
    British Journal of Cancer, 2009, 101 : 1155 - 1161
  • [25] Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells
    Takiuchi, Daisuke
    Eguchi, Hidetoshi
    Nagano, Hiroaki
    Iwagami, Yoshifumi
    Tomimaru, Yoshito
    Wada, Hiroshi
    Kawamoto, Koichi
    Kobayashi, Shogo
    Marubashi, Shigeru
    Tanemura, Masahiro
    Mori, Masaki
    Doki, Yuichiro
    PANCREATOLOGY, 2013, 13 (05) : 517 - 523
  • [26] Molecular mechanism of gemcitabine resistance in pancreatic cancer BxPC-3 cells
    Hara, Haruka
    Sato, Akira
    CANCER SCIENCE, 2025, 116 : 1224 - 1224
  • [27] Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine
    Yokoi, K
    Fidler, IJ
    CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2299 - 2306
  • [28] Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells
    Chen, Yi-Wen
    Liu, Jieh-Yuan
    Lin, Szu-Ting
    Li, Ji-Min
    Huang, Shun-Hong
    Chen, Jing-Yi
    Wu, Jing-Yiing
    Kuo, Cheng-Chin
    Wu, Chieh-Lin
    Lu, Ying-Chieh
    Chen, You-Hsuan
    Fan, Chiao-Yuan
    Huang, Ping-Chun
    Law, Ching-Hsuan
    Lyu, Ping-Chiang
    Chou, Hsiu-Chuan
    Chan, Hong-Lin
    MOLECULAR BIOSYSTEMS, 2011, 7 (11) : 3065 - 3074
  • [29] Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
    Bafna, S.
    Kaur, S.
    Momi, N.
    Batra, S. K.
    BRITISH JOURNAL OF CANCER, 2009, 101 (07) : 1155 - 1161
  • [30] Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells
    Xu, Hongtao
    Paxton, James W.
    Wu, Zimei
    PHARMACEUTICAL RESEARCH, 2016, 33 (07) : 1628 - 1637
12345